CD24 and cancer: Similar results were shown in the MKR tumors, where approximately 73 % of the cancer cells were CD24+ following implantation of the CD24+ control cells, and only approximately 10 % were CD24+ in the CD24+ IGF1R-KD tumors (Fig. 5c).